Document is current
Any future updates will be listed below
-
Authors
Süß, Patrick https://orcid.org/0000-0001-6926-1813
Regensburger, Martin https://orcid.org/0000-0003-2037-9460
Gassner, Heiko https://orcid.org/0000-0002-2172-7386
Winkler, Jürgen https://orcid.org/0000-0003-0630-9204
-
Funding
Funding for this research was provided by:
Universitätsklinikum Erlangen
- License Information
-
More Information
Article History
Received: 1 August 2025
Accepted: 24 October 2025
First Online: 12 November 2025
Declarations
:
: PS was a speaker for Zambon GmbH and received travel compensation from Ever Pharma GmbH. MR was consultant and/or speaker for Zambon GmbH, Ever Pharma GmbH, Abbvie GmbH and Bial GmbH, and he received travel compensation from Desitin. HG received fees from Zambon GmbH and Gerresheimer AG that are not related to the submitted work. JW was a speaker for Zambon GmbH, Bial GmbH and EVER Pharma GmbH. JW is co-owner of the gait analysis patent: EP/13.06.16/EPA 16174268; Application, No./Patent No.: 17734647.5–1115.
